OrbiMed Advisors acquires 1,000,000 Scribe Therapeutics shares valued at $15 million
Reuters2026/07/29 22:48- OrbiMed Advisors, a Scribe Therapeutics director, reported an increase in indirect common-stock holdings to 1,348,825 shares.
- The filing shows the acquisition of 1 million common shares at USD 15.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.

Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
